761. Targeted Killing of HIV Infected Cells Using CCR5-Disrupted Anti-HIV-CAR T Cells
Guillermo S. Romano Ibarra, Thor A. Wagner(Center for Infectious Disease Research), Christopher W. Peterson(University of Washington), Jordan Jarjour(Biogen (United States)), Hans‐Peter Kiem(Fred Hutch Cancer Center), Jaya Sahni(Dallas VA Medical Center), Andrew M. Scharenberg(CTI BioPharma (Italy)), Alexander Astrakhan(Seattle University), Iram Khan, David J. Rawlings(Center for Infectious Disease Research), Malika Hale(University of Washington), Karen Sommer
Cited by 2